Dr. Joseph C Masdeu, MD, PhD
Claim this profileHouston Methodist Neurological Institute
Affiliated Hospitals
Houston Methodist Neurological Institute
Houston Methodist Research Ins
Clinical Trials Joseph C Masdeu, MD, PhD is currently running
Ocrelizumab
for Psychosis
Some people who have what doctors currently call schizophrenia or bipolar disease may actually have a brain disease caused by auto-antibodies. Auto-antibodies are produced when the normal defense mechanism of the body goes wrong and begins to attack the body, similar to "friendly fire." Auto-antibodies attack brain receptors and then the person who has this problem begins to have hallucinations and other manifestations of schizophrenia, like feeling that people can see what they are thinking and also feeling that other people do not like them. If this disease is caused by auto-antibodies, typically the person is well until they are 15 years of age or older, but seldom older than 35 years. Then, in a matter of a few months they begin to have hallucinations and the other symptoms. Doctors still do not know whether some people with schizophrenia or bipolar disease have auto-antibodies attacking their brain. For this reason, in this study some of these patients will receive a treatment that suppresses the auto-antibodies and their symptoms after treatment will be compared with the symptoms of a group of similar patients who are given a preparation that looks like the real treatment, but it is not.
Recruiting
1 award
Phase 1 & 2
5 criteria
Research
for Frontotemporal Dementia
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
Recruiting
1 award
N/A
10 criteria
More about Joseph C Masdeu, MD, PhD
Clinical Trial Related
8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Joseph C Masdeu, MD, PhD has experience with
- Ocrelizumab
- Donanemab
- Nicotine Transdermal Patch
- Placebo Patch
- Florbetaben
- Flortaucipir
Breakdown of trials Joseph C Masdeu, MD, PhD has run
Mild Cognitive Impairment
Dementia
Alzheimer's disease
Alzheimer's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph C Masdeu, MD, PhD specialize in?
Joseph C Masdeu, MD, PhD focuses on Mild Cognitive Impairment and Dementia. In particular, much of their work with Mild Cognitive Impairment has involved treating patients, or patients who are undergoing treatment.
Is Joseph C Masdeu, MD, PhD currently recruiting for clinical trials?
Yes, Joseph C Masdeu, MD, PhD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Joseph C Masdeu, MD, PhD has studied deeply?
Yes, Joseph C Masdeu, MD, PhD has studied treatments such as Ocrelizumab, Donanemab, Nicotine Transdermal Patch.
What is the best way to schedule an appointment with Joseph C Masdeu, MD, PhD?
Apply for one of the trials that Joseph C Masdeu, MD, PhD is conducting.
What is the office address of Joseph C Masdeu, MD, PhD?
The office of Joseph C Masdeu, MD, PhD is located at: Houston Methodist Neurological Institute, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Neurological Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.